Ramesh Paramsothy

2.5k total citations · 3 hit papers
15 papers, 1.8k citations indexed

About

Ramesh Paramsothy is a scholar working on Epidemiology, Infectious Diseases and Genetics. According to data from OpenAlex, Ramesh Paramsothy has authored 15 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 8 papers in Infectious Diseases and 8 papers in Genetics. Recurrent topics in Ramesh Paramsothy's work include Inflammatory Bowel Disease (8 papers), Clostridium difficile and Clostridium perfringens research (7 papers) and Gut microbiota and health (6 papers). Ramesh Paramsothy is often cited by papers focused on Inflammatory Bowel Disease (8 papers), Clostridium difficile and Clostridium perfringens research (7 papers) and Gut microbiota and health (6 papers). Ramesh Paramsothy collaborates with scholars based in Australia, United States and United Kingdom. Ramesh Paramsothy's co-authors include Sudarshan Paramsothy, Hazel M. Mitchell, Michael A. Kamm, Nadeem O. Kaakoush, Susan J. Connor, Rupert W. Leong, Thomas J. Borody, Enmoore Lin, Alissa Walsh and Johan van den Bogaerde and has published in prestigious journals such as The Lancet, Gastroenterology and Gastrointestinal Endoscopy.

In The Last Decade

Ramesh Paramsothy

14 papers receiving 1.7k citations

Hit Papers

Multidonor intensive faecal microbiota transplantation fo... 2017 2026 2020 2023 2017 2018 2017 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial
    2017 910 citations Sudarshan Paramsothy, Michael A. Kamm et al. The Lancet profile →
  2. Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis
    2018 375 citations Sudarshan Paramsothy, Shaun Nielsen et al. Gastroenterology profile →
  3. Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
    2017 328 citations Sudarshan Paramsothy, Ramesh Paramsothy et al. Journal of Crohn s and Colitis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ramesh Paramsothy Australia 9 1.3k 1.0k 520 488 463 15 1.8k
Watson Ng Australia 9 1.1k 0.8× 885 0.8× 445 0.9× 414 0.8× 390 0.8× 29 1.6k
Douglas Samuel Australia 6 1.1k 0.8× 893 0.9× 442 0.8× 408 0.8× 356 0.8× 8 1.5k
Samuel P. Costello Australia 23 1.1k 0.9× 1.1k 1.0× 724 1.4× 525 1.1× 591 1.3× 65 2.2k
Johan van den Bogaerde United Kingdom 14 1.1k 0.9× 886 0.8× 475 0.9× 453 0.9× 399 0.9× 26 1.8k
Melanie Wolfe Canada 6 852 0.7× 776 0.7× 385 0.7× 403 0.8× 277 0.6× 9 1.2k
Noortje Rossen Netherlands 7 869 0.7× 843 0.8× 466 0.9× 424 0.9× 288 0.6× 12 1.3k
Anne Bourrier France 18 810 0.6× 449 0.4× 837 1.6× 167 0.3× 933 2.0× 38 2.0k
J. Cosnes France 6 808 0.6× 316 0.3× 339 0.7× 180 0.4× 511 1.1× 10 1.3k
Christopher D. Packey United States 9 767 0.6× 256 0.2× 185 0.4× 247 0.5× 270 0.6× 17 1.2k
Ari Grinspan United States 16 464 0.4× 476 0.5× 296 0.6× 215 0.4× 191 0.4× 45 922

Countries citing papers authored by Ramesh Paramsothy

Since Specialization
Citations

This map shows the geographic impact of Ramesh Paramsothy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramesh Paramsothy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramesh Paramsothy more than expected).

Fields of papers citing papers by Ramesh Paramsothy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramesh Paramsothy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramesh Paramsothy. The network helps show where Ramesh Paramsothy may publish in the future.

Co-authorship network of co-authors of Ramesh Paramsothy

This figure shows the co-authorship network connecting the top 25 collaborators of Ramesh Paramsothy. A scholar is included among the top collaborators of Ramesh Paramsothy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramesh Paramsothy. Ramesh Paramsothy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Wu, Nan, Steven T. Leach, Ramesh Paramsothy, et al.. (2024). Dietary Emulsifier Exposure in People With Inflammatory Bowel Disease Compared With Healthy Controls: Is There a Cause for Concern?. Inflammatory Bowel Diseases. 30(8). 1241–1250. 12 indexed citations
2.
Paramsothy, Sudarshan, Viraj C. Kariyawasam, Ramesh Paramsothy, et al.. (2024). Effects of Thiopurine Withdrawal on Vedolizumab-Treated Patients With Ulcerative Colitis: A Randomized Controlled Trial. Clinical Gastroenterology and Hepatology. 22(11). 2299–2308.e5. 8 indexed citations
3.
Paramsothy, Sudarshan, Viraj C. Kariyawasam, Ramesh Paramsothy, et al.. (2023). P413 Withdrawal versus continuation of thiopurine in vedolizumab-treated patients with Ulcerative Colitis (VIEWS): a multi-centre randomised controlled trial. Journal of Crohn s and Colitis. 17(Supplement_1). i542–i543. 3 indexed citations
4.
Paramsothy, Sudarshan, Viraj C. Kariyawasam, Ramesh Paramsothy, et al.. (2023). 1029 WITHDRAWAL VERSUS CONTINUATION OF THIOPURINE IN VEDOLIZUMAB-TREATED PATIENTS WITH ULCERATIVE COLITIS (VIEWS): A MULTI-CENTRE RANDOMISED CONTROLLED TRIAL. Gastroenterology. 164(6). S–221. 2 indexed citations
5.
6.
Paramsothy, Sudarshan, Shaun Nielsen, Michael A. Kamm, et al.. (2018). Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis. Gastroenterology. 156(5). 1440–1454.e2. 375 indexed citations breakdown →
7.
8.
Paramsothy, Sudarshan, Ramesh Paramsothy, David T. Rubin, et al.. (2017). Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Journal of Crohn s and Colitis. 11(10). 1180–1199. 328 indexed citations breakdown →
9.
Paramsothy, Sudarshan, Michael A. Kamm, Nadeem O. Kaakoush, et al.. (2017). Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. The Lancet. 389(10075). 1218–1228. 910 indexed citations breakdown →
10.
Paramsothy, Sudarshan, Ramesh Paramsothy, Nadeem O. Kaakoush, et al.. (2017). P589 Faecal microbiota transplantation for inflammatory bowel disease: a systematic review and meta-analysis. Journal of Crohn s and Colitis. 11(suppl_1). S380–S381. 1 indexed citations
11.
Paramsothy, Sudarshan, Ramesh Paramsothy, Michael A. Kamm, et al.. (2017). Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Gastroenterology. 152(5). S1007–S1007. 80 indexed citations
12.
Samaan, Mark, Polychronis Pavlidis, Jonathan Digby‐Bell, et al.. (2017). Golimumab: early experience and medium-term outcomes from two UK tertiary IBD centres. Frontline Gastroenterology. 9(3). 221–231. 9 indexed citations
13.
Paramsothy, Sudarshan, Michael A. Kamm, Alissa Walsh, et al.. (2016). 600 Multi Donor Intense Faecal Microbiota Transplantation is an Effective Treatment for Resistant Ulcerative Colitis: A Randomised Placebo-Controlled Trial. Gastroenterology. 150(4). S122–S123. 23 indexed citations
14.
15.
Paramsothy, Sudarshan, et al.. (2011). Oxidative DNA Damage Levels in IBD Patients Undergoing Infliximab Therapy. Gastroenterology. 140(5). S–278. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Watson Ng Breakdown of academic impact, for papers by Douglas Samuel Breakdown of academic impact, for papers by Samuel P. Costello Breakdown of academic impact, for papers by Johan van den Bogaerde Breakdown of academic impact, for papers by Melanie Wolfe Breakdown of academic impact, for papers by Noortje Rossen Breakdown of academic impact, for papers by Anne Bourrier Breakdown of academic impact, for papers by J. Cosnes Breakdown of academic impact, for papers by Christopher D. Packey Breakdown of academic impact, for papers by Ari Grinspan
Rankless by CCL
2026